According to GlobalData’s medical device pipeline database, nine Revision Hip Replacement devices are in various stages of development globally. GlobalData’s report Revision Hip Replacement provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, five are in active development, while the remaining four are in an inactive stage of development. All devices are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Hip Reconstruction or Hip Replacement is a procedure which involves replacement of the damaged or diseased parts of the hip joint Revision. Hip Replacement is the replacement of the failed Primary Hip implants with a new implant In Revision Hip Replacement any of the damaged components (acetabular or femoral) of Hip joint are replaced
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Revision Hip Replacement pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Revision Hip Replacement devices. Overall, most of these Revision Hip Replacement pipeline devices are being developed by private entities.
Key players involved in the active development of Revision Hip Replacement include JRI Orthopaedics, Exactech, Corin Group, MicroPort Orthopedics and Pro-Dex.
For a complete picture of the developmental pipeline for Revision Hip Replacement devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
